Obstacles and Opportunities for Cholinergic Drug Development in the Treatment of Cognitive Disorders

E-ISSN： 1873-4286|22|14|1981-1985

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.14, 2016-04, pp. : 1981-1985

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nanoparticles in Cancer Treatment: Opportunities and Obstacles

Current Drug Targets, Vol. 19, Iss. 14, 2018-10 ,pp. : 1696-1709

Bentham Science Publishers

Access to resources Recommend Favorite

Development of nicotinic drug therapy for cognitive disorders

By Levin E.D. Rezvani A.H.

European Journal of Pharmacology, Vol. 393, Iss. 1, 2000-03 ,pp. : 141-146

Elsevier

Access to resources Recommend Favorite

Transporters at CNS Barrier Sites: Obstacles or Opportunities for Drug Delivery?

Current Pharmaceutical Design, Vol. 20, Iss. 10, 2014-03 ,pp. : 1422-1449

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Development in Japan: Opportunities and Challenges in Drug Development

By Takahashi Kihito

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 5, 2007-01 ,pp. : 331-338

Adis International

Access to resources Recommend Favorite

Pituitary Disorders: Drug Treatment Options

By Orrego J.J. Barkan A.L.

Drugs, Vol. 59, Iss. 1, 2000-01 ,pp. : 93-106

Adis International

Access to resources Recommend Favorite